References
- PAUWELS R, ANDRIES K, DESMYTER J, SCHOLS D, KUKLA MJ, BRESLIN HJ, RAEYMAECKERS A, VAN GELDER J, WOESTENBORGHS R, HEYKANTS J, SCHELLEKENS K, JANSSEN MAC, DE CLERCQ E, JANSSEN PM: Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature (1990) 343:470–474.
- MERLUZZI VJ, HARGRAVE KD, LABADIA M, GROZINGER K, SKOOG M, Wu JC, SHIH C-K, ECKNER K, HATTOX S, ADAMS J, ROSENTHAL AS, FAANES R, ECKNER RJ, KOUP RA, SULLIVAN JL: Inhibition of 111V-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science (1990) 250:1411–1413.
- GOLDMAN ME, NUNBERG JH, O'BRIEN JA, QUINTERO JC, SCHLEIF WA, FREUND KF, GAUL SL, SAARI WS, WAI JS, HOFFMAN JM, ANDERSON PS, HUPE DJ, EMINI EA, STERN AM: Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity. Proc Natl Acad Sci USA (1991) 88:6863–6867.
- NUNBERG JH, SCHLEM WA, BOOTS El, O'BRIEN JA, QUINTERO JC, HOFFMAN JM, EMINI EA, GOLDMAN ME: Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors. J Virol (1991) 65:4887–4892.
- RICHMAN D, SH1H C-K, LOWY I, ROSE J, PRODANOVICH P. GOFF S, GRIFFIN J: Human immunod-eficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. Proc Natl Acad Sci USA (1991) 88:11241–11245.